Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001415889-23-004099

CHIEF EXECUTIVE OFFICER sold 8,262 shares at $25.36 ($209,541)

  • CHIEF EXECUTIVE OFFICER acquired 67,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-01 Option exercise +22,458 588,922 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Sale −8,262 $25.36 $209,541 580,660 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +9,104 589,764 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +15,476 605,240 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +3,891 609,131 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +7,648 616,779 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +5,782 622,561 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise +2,913 625,474 D
Derivatives
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-01 Option exercise · Restricted Stock Units −22,458 44,918 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Restricted Stock Units −9,104 0 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Performance Stock Units −15,476 0 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Performance Stock Units −3,891 0 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Restricted Stock Units −7,648 7,648 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Performance Stock Units −5,782 5,782 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Grant or award · Performance Stock Units +5,828 5,828 D
GOREVIC JASON N CHIEF EXECUTIVE OFFICER 2023-03-02 Option exercise · Performance Stock Units −2,913 2,915 D
Open-market sales · 8,262 sh · avg $25.36 · $209,541
Loading xslF345X03/form4-03032023_090302.xml…